Trump’s Tariff Fight Escalates: Appeals Court Pauses Block, White House Rails Against Judges

Date:

The legal battle over President Trump’s tariffs has intensified, with an appeals court granting a temporary pause on a ruling that declared them illegal. This reprieve allows the administration to continue its fight to uphold its sweeping trade policies, even as the White House launched a scathing attack on the judges who issued the initial ruling. The core of the dispute centers on the president’s use of emergency powers to impose trade restrictions.

The Court of International Trade had ruled that Trump’s tariff orders “exceed any authority granted to the president,” specifically citing his reliance on the International Emergency Economic Powers Act (IEEPA) to bypass congressional approval. The court’s decision was rooted in the legal applicability of the act, rather than the economic or political implications of the tariffs themselves.

White House press secretary Karoline Leavitt characterized the judicial ruling as “judicial overreach” and a “brazen abuse of their judicial power.” President Trump himself took to social media to express his anger, questioning the judges’ motives. This ongoing legal saga underscores the deep ideological divides over trade policy and the limits of executive authority.

Related articles

Ex-Addicts Plead for Intervention: Funding Gap Could Trigger Suicide Spike

Former gambling addicts are making an emotional appeal to the government, warning that the current funding crisis in...

Meta’s Winning Strategy: Capturing Apple’s UI Genius Alan Dye

Meta is executing a winning strategy by capturing Alan Dye, Apple's UI genius. Dye will join Meta on...

Energy Trade Policies Reshape US-India Commercial Relations

Next week will mark another significant chapter in US-India trade relations as a Trump administration delegation prepares to...

Emergency Services Funding Concerns Raised Amid Pharmaceutical Commitments

The United Kingdom has committed the National Health Service to a 25% spending increase on innovative medicines by...